Archives
Transfection Strategy: From Complexes to Translation
2026-09-24
Transfection success depends on more than reagent choice: DNA concentration, reaction volume, cell state, and scale all shape delivery and expression. This article connects calcium-phosphate optimization findings with the mechanism and practical role of Polyethylenimine Linear (PEI), MW 40,000, helping translational teams choose and validate workflows without treating one protocol as universal.
EZ Cap Cy5 Firefly Luciferase mRNA for Delivery
2026-09-24
Track mRNA uptake and reporter expression in complementary fluorescence and bioluminescence readouts. This workflow pairs the dual-reporter design of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) with practical delivery optimization—and puts emerging MOF carriers in context without assuming they are interchangeable with lipid reagents.
From Nanoadjuvant Biology to Mucosal Imaging
2026-09-23
A PLGA-based vaccine-adjuvant study shows why translational imaging must connect particle localization to immune outcomes. This article outlines how Sulfo-Cy5 carboxylic acid can support that investigation—and where tracer design and controls are essential.
5-Aminolevulinic acid HCl for Heme Assays
2026-09-23
Use 5-Aminolevulinic acid HCl as a controlled pathway-entry perturbation—not simply as a heme supplement—to connect heme flux with bacterial immune evasion, macrophage phenotypes, and porphyrin-based cancer research. This guide combines assay design, practical dosing considerations, and troubleshooting for reproducible workflows.
Dual-Mode mRNA Delivery: From Uptake to Function
2026-09-22
Successful mRNA delivery is not defined by cellular entry alone; it depends on intracellular processing, release, and translation. This thought-leadership article connects the mechanistic findings on LNP surface charge and target-cell V-ATPase activity with a dual-reporter workflow using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) to separate physical delivery from functional expression.
Cy5 amine (non-sulfonated) Labeling Guide
2026-09-22
Cy5 amine (non-sulfonated), SKU A8143, provides a primary amine for covalent attachment of a bright far-red fluorophore to proteins, peptides, polymers, and other compatible biomolecules. It is intended for controlled mixed-solvent research workflows, not direct use as an aqueous dye or for diagnostic and medical applications.
ASB3–MAVS Control of Antiviral Immunity
2026-09-21
The 2024 reference study identifies ASB3 as an E3 ligase that suppresses antiviral innate immunity by directing K48-linked ubiquitination and degradation of MAVS. Its reciprocal genetic, virological, and mechanistic evidence positions ASB3 as a regulatory checkpoint in RIG-I-like receptor signaling and provides a framework for fluorescence-based validation of related host–pathogen mechanisms.
Deracoxib–Doxorubicin Protection in Canine Cells
2026-09-21
The 2017 reference study tested whether Deracoxib could reduce doxorubicin-associated injury in cultured normal canine mammary epithelial cells. Its central finding was that Deracoxib lowered doxorubicin-related cytotoxicity and apoptosis while limiting nitrite accumulation, identifying nitric oxide modulation as a plausible component of the protective response.
Budesonide for Airway Inflammation Research
2026-09-20
Use Budesonide as a reproducible anti-inflammatory benchmark while pairing asthma inflammation models with biomimetic permeability measurements. This workflow helps distinguish biological efficacy from membrane partitioning and supports better decisions in respiratory disease research.
Making mRNA Delivery Visible: From Cargo to Translation
2026-09-19
A translational framework for using ARCA Cy5 EGFP mRNA (5-moUTP) to separate delivery, localization, endosomal escape, and protein expression when evaluating emerging mRNA carriers for ischemic disease.
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-18
Build a direct, dual-readout workflow that separates mRNA uptake from protein expression in mammalian cells. ARCA capping, 5-methoxyuridine modification, Cy5 labeling, and EGFP translation make this reporter useful for benchmarking emerging delivery systems, including biodegradable polyester nanoparticles.
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-09-18
Build transient CRISPR-Cas9 experiments around a Cap1-capped, m1Ψ-modified Cas9 transcript designed for efficient translation and reduced innate immune stimulation. This practical guide connects product handling with mammalian-cell editing, time-course controls, nuclear-export studies, and troubleshooting for reproducible results.
Cl-Amidine: PAD4 Inhibition Evidence & Workflow
2026-09-17
Cl-Amidine trifluoroacetate salt is a research-grade PAD4 inhibitor with a reported in-vitro IC50 of 5.9 μM. Evidence connects PAD4 inhibition with reduced histone citrullination and altered NET biology, while murine septic-shock findings remain preclinical.
KDM3A–METTL16–PDK1 Axis in TKI Resistance
2026-09-17
The reference study identifies a coordinated epigenetic and post-transcriptional mechanism that elevates PDK1 and promotes EGFR-TKI resistance and tumor development. Its findings connect KDM3A-mediated histone demethylation with METTL16-dependent m6A stabilization of PDK1 mRNA, suggesting a mechanistic framework for biomarker development and combination treatment studies.
U3 snoRNA–DDX21 Control of Mitotic Progression
2026-09-16
The reference study shows that U3 snoRNA is an active regulator of mitosis rather than merely a passenger retained on chromosome surfaces. By combining cellular perturbation, localization analysis, and in vitro condensate reconstitution, the authors identify a reciprocal U3 snoRNA–DDX21 system that helps organize the perichromosomal region and supports mitotic progression.
3774 records 7/252 page Previous Next First page 上5页 678910 下5页 Last page